Resultados de la búsqueda 1091-1100 of 70730 for Cancer

1. Esofagectomía - Médicos y departamentos - Mayo Clinic

   American Cancer Society. https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/surgery/recovering-from-cancer-surgery.html. Accessed Feb.

2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Multiple myeloma (MM) is a blood cancer that affects a type of white cell called plasma cell. It mainly affects older individuals and has an average age at ...

3. Oncología (médica) - Ensayos clínicos

   ... Cancer. Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy ...

4. Proton therapy for prostate cancer - Médicos y departamentos - Mayo Clinic

   Proton therapy helps treat prostate cancer while limiting radiation to nearby healthy tissue. Learn how it works, how it's used and what side effects it ...

5. Oncología (médica) - Ensayos clínicos

   ... cancer survivors. Many breast cancer survivors report cancer-related cognitive impairment, which this has recently become a priority in clinical research ...

6. Oncología (médica) - Ensayos clínicos

   A Study of Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples. Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The purpose of ...

7. Oncología (médica) - Ensayos clínicos

   The purpose of this study is to evaluate molecular markers which might be a predictor of pancreatic cancer or precancer by analyzing the secretions (fluid) ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...

9. Oncología (médica) - Ensayos clínicos

   This is an open label, phase I/II, multi-center study in adult participants with metastatic hormone sensitive prostate cancer (mHSPC) and with metastatic ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no clinical evidence of ...